AbbVie Inc (ABBV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AbbVie Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 20 | $127 | $97 | $112.05 | $116.05 | -3.45% |
The Trend in the Analyst Price Target
Over the past 100 days, ABBV's average price target has gone up $1.72.
Over the past 175 days, ABBV's average upside potential has been 16.92%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-11-30 | 20 | 127 | 97 | 112.05 | 104.58 | 7.14% |
| 2020-11-17 | 20 | 127 | 97 | 111.45 | 99.21 | 12.34% |
| 2020-11-10 | 19 | 127 | 97 | 110.84 | 98.87 | 12.11% |
| 2020-10-21 | 18 | 127 | 96 | 109.61 | 82.89 | 32.24% |
| 2020-09-30 | 17 | 127 | 96 | 109.29 | 87.59 | 24.77% |
| 2020-09-10 | 16 | 127 | 96 | 110.00 | 89.65 | 22.7% |
| 2020-09-01 | 16 | 127 | 96 | 110.00 | 92.24 | 19.25% |
| 2020-08-23 | 15 | 127 | 96 | 110.33 | 94.86 | 16.31% |
| 2020-08-22 | 15 | 127 | 96 | 110.33 | 94.86 | 16.31% |
| 2020-08-12 | 15 | 127 | 95 | 109.47 | 95.51 | 14.62% |
| 2020-08-03 | 14 | 127 | 95 | 110.14 | 95.94 | 14.8% |
| 2020-07-22 | 14 | 125 | 93 | 107.93 | 97.70 | 10.47% |
| 2020-07-17 | 14 | 125 | 93 | 107.93 | NA | NA% |
| 2020-07-02 | 14 | 125 | 91 | 107.64 | NA | NA% |
| 2020-06-24 | 15 | 125 | 70 | 104.53 | NA | NA% |
| 2020-06-16 | 15 | 122 | 70 | 101.27 | NA | NA% |
| 2020-06-09 | 15 | 122 | 70 | 100.40 | NA | NA% |
| 2020-06-08 | 14 | 122 | 70 | 98.71 | NA | NA% |
ABBV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The Trend in the Broker Recommendations
Over the past 61 days, ABBV's average broker recommendation rating worsened by 0.03.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABBV as an investment opportunity.
- The number of analysts covering the stock of ABBV is higher than 93.61% of all US stocks.
- ABBV has a higher average analyst price target than 93.74% of Pharmaceutical Products stocks.
- AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 6.54% of Pharmaceutical Products stocks.
- ABBV has a less variance in analysts' estimates than 80.36% of stocks in the mega market cap category.
Make investment decisions regarding ABBV using the data that counts. Try POWR Ratings for free.